Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (855)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
315
17.870
 Why?
Herpes Zoster Vaccine
66
2025
154
16.390
 Why?
Herpesvirus 3, Human
87
2025
336
12.010
 Why?
Antibodies, Viral
67
2026
672
4.990
 Why?
Chickenpox
24
2023
81
4.920
 Why?
Immunity, Cellular
36
2024
272
4.480
 Why?
Chickenpox Vaccine
27
2023
75
3.720
 Why?
Influenza Vaccines
18
2024
529
2.830
 Why?
Vaccines, Attenuated
32
2024
129
2.620
 Why?
HIV Infections
39
2026
3154
2.380
 Why?
Neuralgia, Postherpetic
18
2019
39
2.350
 Why?
Immunocompromised Host
13
2019
201
2.330
 Why?
Antiviral Agents
28
2022
767
2.200
 Why?
Adjuvants, Immunologic
17
2023
245
2.050
 Why?
Simplexvirus
24
2016
82
2.030
 Why?
Acyclovir
27
2016
96
1.970
 Why?
Herpes Simplex
17
2016
98
1.810
 Why?
Vaccination
33
2023
1423
1.780
 Why?
DNA, Viral
24
2018
358
1.670
 Why?
Trypanosoma cruzi
13
2007
39
1.630
 Why?
Papillomavirus Vaccines
13
2018
297
1.490
 Why?
Viral Envelope Proteins
6
2021
98
1.420
 Why?
Herpesvirus 1, Human
10
2016
84
1.390
 Why?
Influenza, Human
13
2024
616
1.350
 Why?
Vaccines, Synthetic
16
2025
138
1.350
 Why?
Pregnancy Complications, Infectious
16
2020
428
1.340
 Why?
T-Lymphocytes
20
2019
1982
1.320
 Why?
Humans
296
2026
144759
1.310
 Why?
Antiretroviral Therapy, Highly Active
13
2017
278
1.290
 Why?
Immunologic Memory
12
2019
366
1.240
 Why?
Aged
92
2024
25913
1.240
 Why?
Aged, 80 and over
47
2022
8265
1.220
 Why?
Immunization, Secondary
13
2017
91
1.210
 Why?
CD4-Positive T-Lymphocytes
13
2023
1129
1.170
 Why?
Antibodies, Protozoan
5
2007
41
1.110
 Why?
Papillomavirus Infections
9
2018
345
1.110
 Why?
Middle Aged
102
2026
35875
1.040
 Why?
Ribosomal Proteins
6
2006
91
1.030
 Why?
Double-Blind Method
33
2026
2029
1.000
 Why?
Chagas Disease
8
2007
42
1.000
 Why?
Pneumococcal Vaccines
4
2026
130
0.980
 Why?
Female
158
2026
78271
0.970
 Why?
Protozoan Proteins
6
2006
93
0.970
 Why?
Male
141
2026
72315
0.930
 Why?
T-Lymphocyte Subsets
6
2019
415
0.930
 Why?
Vaccines, Inactivated
9
2023
70
0.870
 Why?
Receptors, Adrenergic, beta-1
4
2007
24
0.860
 Why?
Viral Vaccines
12
2014
107
0.860
 Why?
Antibodies, Neutralizing
13
2023
340
0.850
 Why?
Incidence
22
2023
2879
0.830
 Why?
Herpesvirus 2, Human
6
2014
27
0.830
 Why?
Virus Latency
4
2014
90
0.790
 Why?
Interferon-gamma
18
2022
784
0.790
 Why?
Immune Sera
4
2020
77
0.780
 Why?
Respiratory Syncytial Virus, Human
3
2019
81
0.770
 Why?
CD8-Positive T-Lymphocytes
5
2018
917
0.760
 Why?
B-Lymphocytes
9
2021
876
0.750
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
851
0.750
 Why?
Injections, Intramuscular
5
2022
141
0.750
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
157
0.710
 Why?
Age Factors
17
2021
3333
0.700
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
39
0.700
 Why?
Rotavirus Infections
3
2017
35
0.690
 Why?
Drug Resistance, Viral
7
2009
122
0.690
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
13
0.690
 Why?
Influenza B virus
6
2012
47
0.650
 Why?
Anti-Retroviral Agents
5
2018
250
0.640
 Why?
Vaccination Coverage
2
2018
103
0.630
 Why?
Rotavirus Vaccines
2
2017
37
0.630
 Why?
Adenovirus Infections, Human
4
2015
15
0.610
 Why?
Infectious Disease Transmission, Vertical
7
2020
193
0.610
 Why?
Adult
77
2026
40449
0.590
 Why?
Down Syndrome
2
2023
534
0.590
 Why?
Th1 Cells
3
2018
139
0.590
 Why?
Polymerase Chain Reaction
13
2019
1054
0.580
 Why?
Clinical Trials as Topic
15
2019
1053
0.580
 Why?
Child, Preschool
43
2026
11787
0.570
 Why?
Insurance Claim Review
1
2019
83
0.570
 Why?
HIV
4
2010
250
0.560
 Why?
AIDS-Related Opportunistic Infections
4
2015
130
0.560
 Why?
Alphapapillomavirus
4
2016
35
0.560
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
50
0.560
 Why?
Cytomegalovirus Infections
4
2015
206
0.560
 Why?
CD4 Lymphocyte Count
14
2017
277
0.550
 Why?
Antibody Formation
8
2023
294
0.550
 Why?
Immunoglobulin G
11
2021
893
0.530
 Why?
Child
60
2026
22633
0.530
 Why?
Dose-Response Relationship, Immunologic
3
2016
76
0.530
 Why?
Virus Shedding
6
2017
48
0.530
 Why?
Infant
31
2023
10034
0.530
 Why?
Pneumonia
1
2023
631
0.510
 Why?
Health Expenditures
1
2019
194
0.510
 Why?
Adolescent
54
2026
22428
0.500
 Why?
Interleukin-2
7
2022
437
0.500
 Why?
Pain
6
2022
779
0.500
 Why?
Herpesviridae Infections
4
2015
150
0.500
 Why?
Cytosine
3
2015
51
0.500
 Why?
Anti-HIV Agents
6
2015
888
0.490
 Why?
Infant, Premature
5
2020
611
0.490
 Why?
Antigens, Viral
21
2017
182
0.480
 Why?
Organophosphonates
2
2015
97
0.480
 Why?
Injections, Subcutaneous
1
2016
164
0.470
 Why?
Cytomegalovirus
7
2006
168
0.470
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.460
 Why?
Guanine
14
2006
87
0.450
 Why?
Follow-Up Studies
22
2019
5408
0.450
 Why?
Refrigeration
2
2018
12
0.450
 Why?
Immunization
5
2014
374
0.440
 Why?
Polyomavirus Infections
1
2015
29
0.440
 Why?
Health Care Costs
1
2018
427
0.440
 Why?
Immunity, Humoral
3
2021
120
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
267
0.430
 Why?
Viral Load
12
2018
526
0.430
 Why?
Skin Diseases
1
2016
149
0.420
 Why?
Oropharynx
1
2014
46
0.420
 Why?
Herpes Genitalis
7
2014
17
0.420
 Why?
Blood
1
2014
109
0.420
 Why?
Drug Combinations
4
2023
390
0.400
 Why?
Infant, Newborn
28
2023
6429
0.400
 Why?
Monocytes
8
2025
538
0.390
 Why?
Immunogenicity, Vaccine
4
2022
36
0.390
 Why?
Vaccines
3
2018
389
0.390
 Why?
T-Lymphocytes, Regulatory
1
2016
389
0.390
 Why?
Herpes Labialis
3
2013
8
0.380
 Why?
Placebos
8
2017
192
0.380
 Why?
Trigeminal Ganglion
2
2003
26
0.380
 Why?
Time Factors
20
2021
7173
0.370
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.360
 Why?
Aging
10
2017
1966
0.350
 Why?
Sensory Receptor Cells
1
2012
101
0.350
 Why?
United States
18
2026
15966
0.350
 Why?
RNA, Viral
21
2018
688
0.350
 Why?
Young Adult
24
2023
14105
0.350
 Why?
Retrospective Studies
16
2023
17066
0.350
 Why?
Communicable Diseases
1
2014
163
0.350
 Why?
Randomized Controlled Trials as Topic
8
2021
1720
0.340
 Why?
Human papillomavirus 18
5
2018
12
0.320
 Why?
Quality of Life
7
2021
3185
0.320
 Why?
Human papillomavirus 16
5
2018
27
0.310
 Why?
Glycoproteins
2
2023
355
0.310
 Why?
Pregnancy
20
2020
7190
0.310
 Why?
Databases, Factual
4
2019
1486
0.310
 Why?
Animals
42
2021
38058
0.300
 Why?
Induced Pluripotent Stem Cells
1
2012
276
0.300
 Why?
Chagas Cardiomyopathy
4
2007
27
0.300
 Why?
Cost-Benefit Analysis
4
2024
634
0.290
 Why?
Poverty
1
2013
529
0.290
 Why?
Frail Elderly
2
2020
134
0.290
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
20
0.290
 Why?
Vaccines, Subunit
5
2021
53
0.290
 Why?
Risk Factors
20
2023
10779
0.290
 Why?
Treatment Outcome
19
2016
11679
0.280
 Why?
Epitopes
4
2005
485
0.270
 Why?
Varicella Zoster Virus Infection
2
2018
27
0.270
 Why?
Meningitis, Viral
3
1997
20
0.260
 Why?
Activities of Daily Living
3
2021
441
0.260
 Why?
Meningitis
1
2008
80
0.260
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.260
 Why?
Seasons
3
2023
556
0.250
 Why?
Autoantibodies
3
2007
1501
0.250
 Why?
Research Design
2
2013
1135
0.250
 Why?
Viral Plaque Assay
8
2012
29
0.250
 Why?
Cytokines
7
2018
2061
0.250
 Why?
Antibodies, Monoclonal
3
2023
1519
0.250
 Why?
Cells, Cultured
19
2012
4154
0.250
 Why?
Recurrence
14
2019
1135
0.250
 Why?
Viremia
5
2018
158
0.250
 Why?
Prospective Studies
25
2019
7990
0.240
 Why?
Neurons
6
2003
1640
0.240
 Why?
Immunocompetence
4
2019
47
0.230
 Why?
Respiratory Syncytial Virus Infections
3
2017
136
0.230
 Why?
Nucleic Acid Hybridization
11
2006
187
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
257
0.220
 Why?
Neoplasms
3
2016
2875
0.220
 Why?
Virus Replication
12
2018
529
0.220
 Why?
Sleep Wake Disorders
4
2013
301
0.220
 Why?
Nucleosides
1
2004
25
0.220
 Why?
Cross Reactions
6
2014
130
0.220
 Why?
Cell Count
2
2005
320
0.220
 Why?
Intestines
2
2018
358
0.220
 Why?
Severity of Illness Index
14
2015
2925
0.220
 Why?
Vaccine Potency
3
2019
6
0.220
 Why?
Transforming Growth Factor beta1
1
2025
178
0.210
 Why?
Viral Proteins
5
2018
355
0.210
 Why?
Molecular Sequence Data
9
2006
2930
0.210
 Why?
Influenza A virus
5
2012
113
0.210
 Why?
Health Resources
2
2019
129
0.210
 Why?
Nonlinear Dynamics
1
2005
95
0.210
 Why?
Interferons
9
1982
188
0.200
 Why?
Phosphoproteins
1
2006
344
0.200
 Why?
Herpesvirus 4, Human
3
2014
176
0.200
 Why?
Cholecalciferol
1
2024
60
0.200
 Why?
Genetic Variation
1
2008
983
0.200
 Why?
Neuralgia
4
2010
144
0.200
 Why?
Immunoassay
2
2017
109
0.200
 Why?
Antibody Affinity
2
2021
60
0.190
 Why?
Long-Term Care
1
2024
117
0.190
 Why?
Cricetinae
6
2007
303
0.190
 Why?
Enterovirus Infections
5
1995
173
0.190
 Why?
Transforming Growth Factor beta
1
2025
479
0.190
 Why?
Encephalitis
2
1995
139
0.190
 Why?
Ganglia, Spinal
2
1993
88
0.190
 Why?
Developing Countries
2
2016
318
0.180
 Why?
CHO Cells
3
2007
171
0.180
 Why?
Pain Measurement
8
2019
552
0.180
 Why?
Lymphocyte Activation
13
2015
1126
0.180
 Why?
Papillomaviridae
3
2011
115
0.180
 Why?
Antibodies, Bacterial
4
2026
148
0.180
 Why?
Recombinant Proteins
4
2018
1370
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Virus Activation
4
2010
95
0.180
 Why?
Longitudinal Studies
8
2018
2947
0.170
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Cell Separation
1
2002
307
0.170
 Why?
Mice
12
2021
18339
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.170
 Why?
Genes, Protozoan
1
2000
13
0.170
 Why?
Virology
1
2001
36
0.170
 Why?
Fluorescent Antibody Technique
6
2016
370
0.160
 Why?
Intermediate Filament Proteins
1
2000
57
0.160
 Why?
Case-Control Studies
5
2018
3604
0.160
 Why?
Cell Line
16
2018
2882
0.160
 Why?
Fetal Diseases
4
1991
191
0.160
 Why?
RNA Helicases
1
2000
31
0.160
 Why?
Amino Acid Sequence
5
2006
2155
0.160
 Why?
Fibroblasts
10
2018
1034
0.160
 Why?
Vitamin D
1
2024
400
0.160
 Why?
Immunoglobulin A
3
2017
214
0.160
 Why?
Health Services for the Aged
1
2001
70
0.160
 Why?
Terminal Repeat Sequences
1
2000
17
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
12
0.160
 Why?
Enterovirus
3
1995
82
0.160
 Why?
HIV-1
5
2018
896
0.160
 Why?
Laboratories
1
2001
109
0.160
 Why?
Feces
3
2017
513
0.160
 Why?
Carrier Proteins
2
2001
737
0.150
 Why?
Acquired Immunodeficiency Syndrome
2
1993
235
0.150
 Why?
Antidepressive Agents
2
2013
248
0.150
 Why?
Cohort Studies
10
2022
5960
0.150
 Why?
Immunoenzyme Techniques
3
2006
200
0.150
 Why?
Retroelements
1
2000
51
0.150
 Why?
Epitope Mapping
3
2005
61
0.150
 Why?
Leukocytes, Mononuclear
5
2010
573
0.150
 Why?
Immunization, Passive
4
1994
87
0.150
 Why?
Dietary Supplements
1
2024
576
0.150
 Why?
Base Sequence
10
2007
2190
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
985
0.150
 Why?
Myocytes, Cardiac
1
2004
556
0.150
 Why?
Immunization Schedule
3
2016
187
0.150
 Why?
Pneumococcal Infections
2
2013
103
0.150
 Why?
Hemophilia A
2
1993
147
0.150
 Why?
Delivery of Health Care, Integrated
1
2022
299
0.150
 Why?
Myocardium
3
2001
939
0.140
 Why?
Heart Transplantation
2
2007
736
0.140
 Why?
Cholera Toxin
1
2018
29
0.140
 Why?
Autophagosomes
1
2018
20
0.140
 Why?
Liver Transplantation
1
2006
823
0.140
 Why?
Infant, Premature, Diseases
3
1995
111
0.140
 Why?
Microbial Sensitivity Tests
8
2005
370
0.140
 Why?
Age Distribution
3
2016
403
0.140
 Why?
Lymphocytes
8
1998
382
0.140
 Why?
Sex Distribution
3
2016
386
0.140
 Why?
Killer Cells, Natural
2
2025
467
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.140
 Why?
Drug Therapy, Combination
4
2016
1047
0.140
 Why?
Viral Fusion Proteins
1
2017
21
0.130
 Why?
Regression Analysis
2
2019
1003
0.130
 Why?
Simian virus 40
11
1977
24
0.130
 Why?
Immune Evasion
1
2018
64
0.130
 Why?
Lysosomes
1
2018
128
0.130
 Why?
Genes, Viral
2
2006
90
0.130
 Why?
Multivariate Analysis
2
2018
1539
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
77
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
52
0.130
 Why?
Protein Subunits
1
2018
226
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Hepatitis B Vaccines
2
2026
43
0.130
 Why?
Cell Division
5
2003
766
0.130
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
Cryopreservation
1
2018
110
0.130
 Why?
Observational Studies as Topic
1
2017
129
0.130
 Why?
Cost of Illness
5
2014
321
0.130
 Why?
Body Mass Index
1
2026
2438
0.130
 Why?
Models, Biological
1
2005
1821
0.130
 Why?
Infectious Mononucleosis
2
1991
10
0.130
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.130
 Why?
Receptors, Muscarinic
1
1996
20
0.130
 Why?
Receptors, Adrenergic, beta-2
1
1996
35
0.120
 Why?
Infusions, Intravenous
2
2016
423
0.120
 Why?
Africa
1
2017
116
0.120
 Why?
Foscarnet
3
2003
20
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Depression
3
2013
1558
0.120
 Why?
Comorbidity
3
2019
1658
0.120
 Why?
Lopinavir
1
2016
30
0.120
 Why?
Atazanavir Sulfate
1
2016
42
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Ribavirin
2
1994
80
0.120
 Why?
Peptide Fragments
3
2007
699
0.120
 Why?
Frailty
1
2019
198
0.120
 Why?
Autophagy
1
2018
286
0.120
 Why?
HIV Protease Inhibitors
1
2016
69
0.120
 Why?
Ritonavir
1
2016
75
0.110
 Why?
Bone Marrow Transplantation
3
1990
294
0.110
 Why?
Dipeptides
1
2015
57
0.110
 Why?
Lymphocyte Subsets
1
2015
83
0.110
 Why?
Genotype
3
2008
1833
0.110
 Why?
Brain Stem
1
1995
95
0.110
 Why?
BK Virus
1
2015
17
0.110
 Why?
Chronic Disease
6
2019
1813
0.110
 Why?
Drug Administration Schedule
3
2026
779
0.110
 Why?
Host-Pathogen Interactions
1
2018
371
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
675
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
264
0.110
 Why?
Hospitalization
2
2023
2433
0.110
 Why?
Data Interpretation, Statistical
3
2019
372
0.110
 Why?
Guatemala
1
2016
345
0.110
 Why?
Propylene Glycols
1
2015
27
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
449
0.110
 Why?
Medication Reconciliation
1
2015
31
0.110
 Why?
Sphingosine
1
2015
45
0.110
 Why?
Global Health
1
2018
401
0.110
 Why?
Infant, Newborn, Diseases
1
2016
113
0.110
 Why?
Reproducibility of Results
5
2013
3409
0.110
 Why?
Transfusion Reaction
1
1995
63
0.110
 Why?
COS Cells
2
2007
181
0.110
 Why?
Maus Elberfeld virus
2
1991
5
0.110
 Why?
Survival Rate
3
2016
2089
0.110
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.110
 Why?
Maternal-Fetal Exchange
3
1995
169
0.110
 Why?
Immunity, Mucosal
2
2012
98
0.110
 Why?
Chlamydia trachomatis
2
1991
49
0.110
 Why?
Histocompatibility Antigens Class I
1
1996
202
0.100
 Why?
Species Specificity
3
2006
574
0.100
 Why?
Hemagglutinins, Viral
1
1994
8
0.100
 Why?
Clinical Trials, Phase III as Topic
3
2021
117
0.100
 Why?
Laryngeal Diseases
1
1994
31
0.100
 Why?
DNA-Directed DNA Polymerase
2
1992
48
0.100
 Why?
Rats
4
2006
5597
0.100
 Why?
Lymphoma
1
2015
232
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
126
0.100
 Why?
Autoantigens
1
1996
429
0.100
 Why?
Zidovudine
2
2015
77
0.100
 Why?
Lamivudine
2
2015
65
0.100
 Why?
Analgesics
3
2010
228
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Needs Assessment
1
2016
404
0.100
 Why?
Placenta
2
1991
780
0.100
 Why?
Cross-Over Studies
2
2013
601
0.100
 Why?
Ethics, Research
1
2013
32
0.100
 Why?
Anti-Inflammatory Agents
3
2013
474
0.100
 Why?
Research Subjects
1
2013
41
0.100
 Why?
Practice Guidelines as Topic
2
2017
1560
0.100
 Why?
Mice, Inbred BALB C
3
2006
1253
0.100
 Why?
Epitopes, T-Lymphocyte
1
2014
175
0.100
 Why?
RNA Probes
2
1991
12
0.090
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
293
0.090
 Why?
Health Status
2
2010
836
0.090
 Why?
Dose-Response Relationship, Drug
4
2026
2027
0.090
 Why?
Measles Vaccine
1
2012
19
0.090
 Why?
Risk Assessment
4
2016
3671
0.090
 Why?
Picornaviridae Infections
2
1990
50
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
94
0.090
 Why?
Autoimmune Diseases
1
1996
463
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Drug Resistance, Microbial
4
2001
69
0.090
 Why?
Immunosuppressive Agents
3
2015
846
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Colorado
4
2018
4564
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
Flow Cytometry
5
2017
1173
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
177
0.090
 Why?
Indoles
1
2015
501
0.090
 Why?
Efficiency
1
2012
103
0.090
 Why?
Linear Models
2
2010
854
0.090
 Why?
Chorioamnionitis
1
1991
45
0.080
 Why?
Cytotoxicity Tests, Immunologic
2
1996
37
0.080
 Why?
Gastroenteritis
2
1989
63
0.080
 Why?
Mutation
5
2009
4089
0.080
 Why?
Insurance, Health
1
2014
302
0.080
 Why?
Macrophages
3
2005
1511
0.080
 Why?
Neurogenesis
1
2012
156
0.080
 Why?
Neural Stem Cells
1
2012
166
0.080
 Why?
Sequence Alignment
2
2008
366
0.080
 Why?
Drug Design
1
2012
173
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
15
0.080
 Why?
Epidemiological Monitoring
3
2018
69
0.080
 Why?
Cervix Uteri
1
2010
50
0.080
 Why?
Exanthema
1
2011
84
0.080
 Why?
Sensitivity and Specificity
3
2009
1985
0.080
 Why?
Serum
1
2010
58
0.080
 Why?
Adenoviridae
9
2005
199
0.080
 Why?
Herpesviridae
2
1981
22
0.080
 Why?
Electrocardiography
2
2005
662
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
31
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Heart Rate
2
2006
855
0.080
 Why?
Antigen-Presenting Cells
5
2010
160
0.080
 Why?
Immunoglobulin M
1
1991
284
0.080
 Why?
Enterovirus B, Human
2
1988
25
0.080
 Why?
Dermatomyositis
1
1989
24
0.080
 Why?
Health Services Accessibility
1
2018
1098
0.080
 Why?
Poliovirus
2
2001
73
0.080
 Why?
Respiratory Tract Infections
1
1994
397
0.080
 Why?
DNA, Kinetoplast
2
2006
2
0.080
 Why?
Medicaid
1
2014
461
0.080
 Why?
Receptors, Virus
2
2006
96
0.070
 Why?
Placenta Diseases
1
1989
19
0.070
 Why?
Protozoan Infections
1
1989
11
0.070
 Why?
DNA Primers
2
2009
512
0.070
 Why?
Drug Stability
1
2009
164
0.070
 Why?
Thymidine Kinase
4
2001
16
0.070
 Why?
Surveys and Questionnaires
7
2021
6048
0.070
 Why?
Pilot Projects
1
2015
1886
0.070
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
50
0.070
 Why?
Geriatrics
1
2010
96
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
65
0.070
 Why?
Gene Expression
2
2006
1490
0.070
 Why?
Vagina
1
2010
201
0.070
 Why?
Muscles
1
1989
333
0.070
 Why?
Hydrocortisone
1
2010
304
0.070
 Why?
In Vitro Techniques
6
2003
1047
0.070
 Why?
Geriatric Assessment
1
2010
233
0.070
 Why?
Postoperative Complications
2
2000
2919
0.070
 Why?
Kinetics
2
2010
1627
0.070
 Why?
Administration, Intranasal
1
2008
93
0.070
 Why?
Poisson Distribution
2
2005
78
0.070
 Why?
Interferon Type I
1
1989
145
0.070
 Why?
Picornaviridae
1
1988
18
0.070
 Why?
Lipid A
2
2018
28
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
28
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Anticonvulsants
1
2010
235
0.070
 Why?
Evidence-Based Practice
1
2010
238
0.070
 Why?
Immunosorbent Techniques
1
2007
18
0.070
 Why?
Data Collection
1
2010
633
0.060
 Why?
Quality-Adjusted Life Years
1
2007
121
0.060
 Why?
Spinal Cord
2
2001
380
0.060
 Why?
Cricetulus
1
2007
118
0.060
 Why?
Prevalence
4
2018
2834
0.060
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Acute Kidney Injury
1
2015
865
0.060
 Why?
Inhibitory Concentration 50
1
2006
91
0.060
 Why?
Vero Cells
1
2006
84
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
45
0.060
 Why?
Research
1
2010
431
0.060
 Why?
Immunoglobulin Fragments
1
2006
11
0.060
 Why?
Public Health
1
2012
566
0.060
 Why?
Animal Diseases
1
2006
8
0.060
 Why?
Neutralization Tests
5
2012
76
0.060
 Why?
Pregnancy Outcome
1
2010
476
0.060
 Why?
NIH 3T3 Cells
1
2006
148
0.060
 Why?
Administration, Topical
4
2013
150
0.060
 Why?
Veterans
1
2018
1603
0.060
 Why?
Cyclic AMP
1
2007
209
0.060
 Why?
Immunoglobulin Variable Region
1
2006
80
0.060
 Why?
Random Allocation
6
1992
363
0.060
 Why?
Meningococcal Vaccines
1
2006
58
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1953
0.060
 Why?
Trees
1
2006
67
0.060
 Why?
Kaplan-Meier Estimate
3
2016
965
0.060
 Why?
Hepatitis A Vaccines
1
2026
20
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Hybridization, Genetic
9
1974
74
0.060
 Why?
Pneumonia, Viral
2
1990
384
0.060
 Why?
Logistic Models
2
2010
2117
0.060
 Why?
Endocytosis
1
2006
168
0.060
 Why?
Motor Activity
1
2010
721
0.060
 Why?
Bone Marrow
2
1984
304
0.060
 Why?
Sequence Analysis, DNA
3
2007
824
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
27
0.060
 Why?
Hepatitis, Viral, Human
1
2005
20
0.060
 Why?
Antineoplastic Agents
2
2016
2194
0.060
 Why?
Proportional Hazards Models
1
2009
1325
0.060
 Why?
HLA Antigens
3
1987
225
0.060
 Why?
Predictive Value of Tests
3
2010
2115
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
561
0.060
 Why?
Normal Distribution
1
2005
22
0.060
 Why?
Evaluation Studies as Topic
3
1996
166
0.050
 Why?
Cell Differentiation
1
2012
2050
0.050
 Why?
Blotting, Western
3
2015
1187
0.050
 Why?
Organ Transplantation
1
2008
247
0.050
 Why?
Transfection
1
2007
940
0.050
 Why?
Conservation of Natural Resources
1
2006
132
0.050
 Why?
Open Reading Frames
2
2007
132
0.050
 Why?
Autopsy
2
2001
94
0.050
 Why?
Mammals
1
2006
293
0.050
 Why?
Neurons, Afferent
1
2005
102
0.050
 Why?
Disease Outbreaks
1
1988
422
0.050
 Why?
Risk
3
2016
911
0.050
 Why?
Receptors, Cholinergic
1
2004
41
0.050
 Why?
Macaca radiata
2
2001
15
0.050
 Why?
Cell Culture Techniques
1
2006
375
0.050
 Why?
Cell Adhesion Molecules
1
2005
178
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
61
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
64
0.050
 Why?
Mental Health
1
2010
790
0.050
 Why?
Sex Factors
2
2003
2112
0.050
 Why?
Demography
2
2018
288
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Receptors, Cell Surface
1
2005
377
0.050
 Why?
Down-Regulation
1
2025
627
0.050
 Why?
2-Aminopurine
2
2007
8
0.050
 Why?
RNA
2
1988
940
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2145
0.050
 Why?
Membrane Glycoproteins
1
2005
496
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
246
0.050
 Why?
Multicenter Studies as Topic
2
2001
405
0.050
 Why?
Adaptive Immunity
2
2017
169
0.050
 Why?
Biopsy
2
2000
1075
0.050
 Why?
Argentina
3
2006
30
0.050
 Why?
Poliomyelitis
2
2001
35
0.050
 Why?
Dendritic Cells
1
2025
499
0.050
 Why?
Maltose-Binding Proteins
1
2001
13
0.040
 Why?
Neuroblastoma
1
2003
174
0.040
 Why?
Forecasting
3
2010
391
0.040
 Why?
Hepatitis C
1
2004
254
0.040
 Why?
Glutathione Transferase
1
2001
100
0.040
 Why?
Cell Nucleus
3
1991
618
0.040
 Why?
Respirovirus Infections
2
1991
14
0.040
 Why?
Spondylarthropathies
1
2021
5
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Peripheral Nerves
1
2001
72
0.040
 Why?
Blotting, Southern
1
2000
85
0.040
 Why?
Expressed Sequence Tags
1
2000
43
0.040
 Why?
Fatal Outcome
1
2001
307
0.040
 Why?
Endocardium
1
2000
31
0.040
 Why?
Alanine
1
2001
171
0.040
 Why?
Mutagenesis
1
2001
192
0.040
 Why?
Cloning, Molecular
1
2001
540
0.040
 Why?
Blotting, Northern
1
2000
204
0.040
 Why?
Secondary Prevention
2
2013
254
0.040
 Why?
Phosphorylation
2
2002
1732
0.040
 Why?
Genome, Viral
1
2002
218
0.040
 Why?
Virion
1
2001
111
0.040
 Why?
Sex Characteristics
2
2017
790
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Amino Acid Motifs
1
2000
224
0.040
 Why?
Consensus Sequence
1
2000
74
0.040
 Why?
DEAD-box RNA Helicases
1
2000
90
0.040
 Why?
Canada
2
2012
428
0.040
 Why?
Psoriasis
1
2021
112
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Immunity, Innate
1
2025
846
0.040
 Why?
Chromosome Mapping
1
2000
510
0.040
 Why?
Autoimmunity
1
2005
926
0.040
 Why?
Transcription, Genetic
5
2000
1496
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
396
0.040
 Why?
Enterotoxins
2
1994
89
0.040
 Why?
Sleep
1
2006
901
0.040
 Why?
Recombinant Fusion Proteins
1
2001
675
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2527
0.040
 Why?
Saponins
1
2018
11
0.030
 Why?
Hematopoietic Stem Cells
1
1982
420
0.030
 Why?
Seroconversion
1
2018
49
0.030
 Why?
Saliva
2
2010
249
0.030
 Why?
Haptoglobins
1
2018
66
0.030
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Drug Compounding
1
2018
107
0.030
 Why?
Protein Precursors
1
2018
137
0.030
 Why?
Immunologic Techniques
2
1994
38
0.030
 Why?
Celiac Disease
1
2021
308
0.030
 Why?
Glucosides
1
2017
55
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
10
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
339
0.030
 Why?
Health Surveys
1
2019
518
0.030
 Why?
International Cooperation
1
2018
198
0.030
 Why?
Internationality
1
2018
156
0.030
 Why?
Graft Rejection
1
2000
540
0.030
 Why?
Chemotaxis
1
2017
122
0.030
 Why?
Zambia
1
2017
57
0.030
 Why?
Zimbabwe
1
2017
76
0.030
 Why?
Antigens, Bacterial
1
2017
125
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Tanzania
1
2017
73
0.030
 Why?
Plasma
1
2018
225
0.030
 Why?
Patient Safety
1
2020
347
0.030
 Why?
Propanolamines
1
1996
40
0.030
 Why?
Recovery of Function
1
2021
707
0.030
 Why?
Cerebrospinal Fluid
2
1993
88
0.030
 Why?
Acute Disease
2
2011
1030
0.030
 Why?
Immune Tolerance
4
1998
379
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Sinusitis
1
1999
228
0.030
 Why?
Biomarkers
2
2018
4271
0.030
 Why?
False Negative Reactions
1
1996
60
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
False Positive Reactions
1
1996
121
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
47
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Analysis of Variance
2
2011
1306
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Half-Life
2
1992
151
0.030
 Why?
Depressive Disorder
1
1998
387
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
250
0.030
 Why?
Cross-Sectional Studies
4
2011
5868
0.030
 Why?
Chi-Square Distribution
2
2013
529
0.030
 Why?
Nausea
1
2015
111
0.030
 Why?
Vomiting
1
2015
130
0.030
 Why?
Area Under Curve
1
2015
330
0.030
 Why?
Bromodeoxyuridine
2
2007
79
0.030
 Why?
Fingolimod Hydrochloride
1
2015
39
0.030
 Why?
Disease Susceptibility
1
1996
348
0.030
 Why?
Gene Regulatory Networks
1
2017
318
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
72
0.030
 Why?
Breast Feeding
1
2018
448
0.030
 Why?
Belgium
1
2014
11
0.030
 Why?
Neutropenia
1
2015
155
0.030
 Why?
Headache
1
2015
150
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
5
0.030
 Why?
HLA-A2 Antigen
1
2014
35
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Rubella
1
1974
22
0.030
 Why?
Culture Media
2
1984
161
0.030
 Why?
Immunoblotting
1
1994
300
0.030
 Why?
Tetanus Toxoid
1
1994
34
0.030
 Why?
Probability
2
2005
310
0.030
 Why?
Drugs, Investigational
1
2014
31
0.030
 Why?
Bacterial Proteins
1
2000
955
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
29
0.030
 Why?
Statistics, Nonparametric
2
2004
427
0.020
 Why?
Anemia
1
2015
188
0.020
 Why?
Seroepidemiologic Studies
1
2014
172
0.020
 Why?
Phenotype
1
2002
3162
0.020
 Why?
Thrombocytopenia
1
2015
205
0.020
 Why?
Developed Countries
1
2013
38
0.020
 Why?
Haplorhini
8
1974
52
0.020
 Why?
Mortality
1
2015
375
0.020
 Why?
Drug Tolerance
1
1992
100
0.020
 Why?
Human papillomavirus 6
1
2011
2
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1169
0.020
 Why?
Genetics, Microbial
3
1971
11
0.020
 Why?
Skin
2
1989
755
0.020
 Why?
Safety
1
1994
356
0.020
 Why?
Genitalia, Female
1
2012
42
0.020
 Why?
gamma-Globulins
1
1991
14
0.020
 Why?
Antibodies, Heterophile
1
1991
13
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Adrenal Cortex Hormones
1
2015
478
0.020
 Why?
Phylogeny
2
2006
1016
0.020
 Why?
Absenteeism
1
2012
53
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Metabolomics
1
2017
727
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
Early Detection of Cancer
1
2016
463
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
North America
1
2012
310
0.020
 Why?
Diagnosis, Differential
3
2009
1489
0.020
 Why?
Tritium
7
1974
68
0.020
 Why?
Europe
1
2012
412
0.020
 Why?
Inflammation
2
2017
2878
0.020
 Why?
Schwann Cells
1
1990
33
0.020
 Why?
Chlamydia Infections
1
1991
81
0.020
 Why?
Bacterial Infections
2
2001
246
0.020
 Why?
Antigens
2
1970
347
0.020
 Why?
DNA
4
1988
1463
0.020
 Why?
Cell Proliferation
1
2018
2496
0.020
 Why?
Rhinovirus
1
1990
57
0.020
 Why?
Antigens, Surface
2
1987
157
0.020
 Why?
Serotyping
2
1988
32
0.020
 Why?
Health Planning Guidelines
1
2010
24
0.020
 Why?
Self Administration
1
2010
124
0.020
 Why?
Gene Expression Profiling
1
2017
1782
0.020
 Why?
Gestational Age
2
1989
975
0.020
 Why?
Hepatitis B Antibodies
1
2009
6
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
881
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
In Situ Hybridization
2
2001
319
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Spermatocidal Agents
1
1989
7
0.020
 Why?
Ribonucleosides
1
1989
7
0.020
 Why?
Immunohistochemistry
1
1993
1716
0.020
 Why?
Reference Values
1
2011
797
0.020
 Why?
Physical Examination
1
2010
239
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
675
0.020
 Why?
Thymidine
4
1980
60
0.020
 Why?
RNA, Antisense
1
1988
18
0.020
 Why?
Reference Standards
1
2009
177
0.020
 Why?
Nasal Mucosa
1
2009
112
0.020
 Why?
Astrocytes
1
1990
222
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Reoviridae
1
1988
38
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
38
0.020
 Why?
Measles
1
1989
46
0.020
 Why?
Hepatitis
1
1988
43
0.020
 Why?
Disease Progression
1
2016
2847
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Cancer Vaccines
1
2009
160
0.020
 Why?
Reoviridae Infections
1
1988
55
0.020
 Why?
Neoplasms, Experimental
1
1969
173
0.020
 Why?
Fetus
1
1992
803
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.020
 Why?
Health Services Needs and Demand
1
2010
280
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
415
0.020
 Why?
Body Fluids
1
1987
70
0.020
 Why?
Australia
1
2008
286
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Biliary Atresia
1
1988
158
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Apoptosis
1
2015
2430
0.020
 Why?
Telomere
1
2010
288
0.020
 Why?
Valine
1
2007
80
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
136
0.020
 Why?
Embryo, Mammalian
3
1973
232
0.010
 Why?
Interleukin-4
2
1998
206
0.010
 Why?
Amino Acid Substitution
1
2007
304
0.010
 Why?
Kidney
9
1975
1495
0.010
 Why?
RNA, Ribosomal
1
2006
168
0.010
 Why?
Statistics as Topic
1
2006
284
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
34
0.010
 Why?
Anti-Bacterial Agents
2
1999
1907
0.010
 Why?
Ketones
1
1986
53
0.010
 Why?
Nectins
1
2005
7
0.010
 Why?
Gene Amplification
1
2006
120
0.010
 Why?
Lymphoproliferative Disorders
1
1985
57
0.010
 Why?
Residence Characteristics
1
2008
377
0.010
 Why?
Mass Screening
1
2014
1347
0.010
 Why?
Factor Analysis, Statistical
1
2006
293
0.010
 Why?
Carbon Isotopes
5
1973
144
0.010
 Why?
California
1
2006
475
0.010
 Why?
Streptococcus pneumoniae
1
2006
177
0.010
 Why?
Chromosomes, Human
1
1984
41
0.010
 Why?
Toll-Like Receptor 2
1
2005
126
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
223
0.010
 Why?
Hexuronic Acids
1
1984
23
0.010
 Why?
Glucuronic Acid
1
1984
25
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
279
0.010
 Why?
Toll-Like Receptors
1
2005
194
0.010
 Why?
Alginates
1
1984
49
0.010
 Why?
Freezing
1
1984
86
0.010
 Why?
Filtration
1
1984
70
0.010
 Why?
Polyethylene Glycols
1
1989
654
0.010
 Why?
Culture Techniques
4
1973
67
0.010
 Why?
Bone Marrow Cells
1
1984
320
0.010
 Why?
RNA, Small Interfering
1
2005
635
0.010
 Why?
Fetal Blood
1
1985
342
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Socioeconomic Factors
1
2007
1326
0.010
 Why?
Up-Regulation
1
2005
851
0.010
 Why?
Agammaglobulinemia
1
1982
36
0.010
 Why?
NF-kappa B
1
2005
661
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
Prognosis
1
2010
4282
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Rural Population
1
2006
650
0.010
 Why?
Interleukin-6
1
2005
780
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
331
0.010
 Why?
Temperature
1
1984
679
0.010
 Why?
Cell Survival
1
1984
1098
0.010
 Why?
Brain
1
1993
2933
0.010
 Why?
Administration, Oral
2
1997
847
0.010
 Why?
Phytohemagglutinins
1
1980
29
0.010
 Why?
Serum Albumin
1
2001
147
0.010
 Why?
Disease Models, Animal
1
1991
4557
0.010
 Why?
Neuroglia
1
2001
172
0.010
 Why?
Phagocytosis
1
1982
299
0.010
 Why?
Ribosomes
1
2001
191
0.010
 Why?
Cell Communication
1
1982
324
0.010
 Why?
Leukocytes
1
1981
295
0.010
 Why?
Ambulatory Care
1
2004
600
0.010
 Why?
Air Microbiology
1
1980
50
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
19
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
37
0.010
 Why?
Immunoglobulins
1
1979
160
0.010
 Why?
Mitogens
1
1978
55
0.010
 Why?
Lectins
1
1978
44
0.010
 Why?
Steroids
1
1999
160
0.010
 Why?
Rabbits
1
1979
648
0.010
 Why?
Th2 Cells
1
1998
171
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
410
0.010
 Why?
Cross Infection
1
1980
262
0.010
 Why?
Centrifugation, Density Gradient
3
1971
40
0.010
 Why?
Antigen-Antibody Complex
1
1997
72
0.010
 Why?
Interleukin-10
1
1998
309
0.010
 Why?
Combined Modality Therapy
1
1999
1266
0.010
 Why?
Erythrocytes
1
1982
757
0.010
 Why?
Adenoviridae Infections
1
1975
20
0.010
 Why?
Evidence-Based Medicine
1
1999
732
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Patient Selection
1
1999
719
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
7
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Heart Defects, Congenital
2
1993
914
0.010
 Why?
Molecular Biology
2
1971
59
0.010
 Why?
Sucrose
2
1971
112
0.010
 Why?
Chlorides
2
1971
142
0.010
 Why?
Complement Fixation Tests
2
1984
5
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Pulmonary Fibrosis
1
1975
395
0.010
 Why?
Genes
1
1971
226
0.010
 Why?
Population Surveillance
1
1993
485
0.000
 Why?
Stress, Psychological
1
1998
1152
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
9
0.000
 Why?
Kidney Transplantation
1
1975
704
0.000
 Why?
Suspensions
1
1987
29
0.000
 Why?
Ribonucleases
1
1987
49
0.000
 Why?
Chloroquine
1
1987
53
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
193
0.000
 Why?
Leukocyte Count
1
1985
316
0.000
 Why?
Mitosis
1
1985
200
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
364
0.000
 Why?
Serologic Tests
1
1983
53
0.000
 Why?
Histocompatibility Antigens
2
1974
102
0.000
 Why?
Infusions, Parenteral
1
1982
41
0.000
 Why?
Leukemia
1
1983
245
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
3
0.000
 Why?
Air Movements
1
1980
10
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
92
0.000
 Why?
Liver
1
1988
1887
0.000
 Why?
Communicable Disease Control
1
1980
86
0.000
 Why?
Methods
1
1978
69
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
46
0.000
 Why?
Hospitals, Pediatric
1
1980
556
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
269
0.000
 Why?
Cadaver
1
1975
304
0.000
 Why?
Transplantation, Homologous
1
1975
415
0.000
 Why?
Genetic Code
1
1971
25
0.000
 Why?
Nucleic Acid Denaturation
1
1971
32
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
50
0.000
 Why?
Molecular Weight
1
1971
327
0.000
 Why?
Carbon
1
1971
203
0.000
 Why?
DNA Replication
1
1971
251
0.000
 Why?
Hot Temperature
1
1971
407
0.000
 Why?
Lung
1
1975
4109
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (855) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)